TABLE 3.
Transplant restart level | Description of conditions | Description of activity |
---|---|---|
Restart phase 1: limited increase in activity | A significant flattening of the pandemic curve is observed in the jurisdiction. This includes a stable number of new cases; and some stabilization in ward/ICU bed utilization |
|
Restart phase 2: moderate increase in transplant activity | The number of new COVID cases is flat or decreasing for a period of time (eg, >2 weeks) and ICU and ward bed utilization has been at a stable level for >2 weeks at the transplant hospital |
|
Restart phase 3: near normal transplant activity | Prolonged stability and/or decreases in COVID activity is observed along with prolonged stability or decreases in hospital ICU/ward bed utilization. ICUs are running consistently below capacity at transplant hospital |
|
Abbreviations: NDD, neurological determination of death; DCD, donation after cardiocirculatory death; ECD, exceptional criteria donor; SCD, standard criteria donor; PRA, panel reactive antibody; SPK, simultaneous pancreas-kidney; PAK, pancreas after kidney; PTA, pancreas transplant alone; LVAD, left ventricular assist device.
Modified from Trillium Gift of Life Network (TGLN) Ontario criteria for phased restart of transplant activity. The Table is provided only as a rough guidance to programs and should take into account other jurisdictional issues.